Journal Article

Oral Treatment for <i>Mycobacterium ulcerans</i> Infection: Results From a Pilot Study in Benin

Annick Chauty, Marie-Françoise Ardant, Laurent Marsollier, Gerd Pluschke, Jordi Landier, Ambroise Adeye, Aimé Goundoté, Jane Cottin, Titilola Ladikpo, Therese Ruf and Baohong Ji

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 52, issue 1, pages 94-96
Published in print January 2011 | ISSN: 1058-4838
Published online January 2011 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1093/cid/ciq072
Oral Treatment for Mycobacterium ulcerans Infection: Results From a Pilot Study in Benin

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

Mycobacterium ulcerans infection is responsible for severe skin lesions in sub-Saharan Africa. We enrolled 30 Beninese patients with Buruli ulcers in a pilot study to evaluate efficacy of an oral chemotherapy using rifampicin plus clarithromycin during an 8-week period. The treatment was well tolerated, and all patients were healed by 12 months after initiation of therapy without relapse.

Journal Article.  1966 words. 

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.